Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a cross-sectional UK study

Shima Espahbodi, Paul Bassett, Charlotte Cavill, Mandy Freeth, John Hole, Raj Sengupta

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

OBJECTIVES: To determine factors associated with absenteeism, presenteeism, work productivity loss (WPL), and daily activity impairment in UK patients with AxSpA using standardised measures.

METHODS: 490 patients with AxSpA completed (1) Work Productivity and Impairment questionnaire (WPAI), providing measures for absenteeism, presenteeism, WPL and daily activity impairment, and (2) BASDAI, BASFI, BASMI, Jenkins Sleep scale, Patient Global Assessment disease activity (PGA), back pain night and anytime, EQ-5D for mobility, self-care, daily activities, pain/discomfort, anxiety/depression, EQ-VAS Health State Today, FACIT fatigue, for health-related disease factors. Multivariate linear and logistic regression determined associations between WPAI measures and health-related factors.

RESULTS: 301(61%) patients provided WPAI measurements, 76% were male, 87% HLA-B27+. Mean (SD) WPAI scores for absenteeism were 5.1%(19.2), presenteeism 22%(24.3), WPL 23.2%(25.7), activity impairment 34.8%(27.3). Absenteeism was associated with higher fatigue levels and more likely in patients with nrAxSpA. Presenteeism and WPL were both associated higher fatigue levels, BASDAI, and BASFI respectively. Daily activity impairment was associated with higher fatigue levels, BASFI, PGA, EQ-VAS, and smoking.

CONCLUSIONS: Work productivity and impairment are associated with fatigue, disease activity, and functional ability in UK patients with AxSpA. The strong association of fatigue with all work measures as well as with daily activity impairment emphasises the need to better understand the impact of fatigue on patients' quality of life. Improving fatigue may help to optimise work status.

Original languageEnglish
Pages (from-to)571-578
Number of pages8
JournalClinical and Experimental Rheumatology
Volume35
Issue number4
Publication statusPublished - 1 Jul 2017

Fingerprint

Fatigue
Cross-Sectional Studies
Efficiency
Absenteeism
Prostaglandins A
Health
HLA-B27 Antigen
Aptitude
Back Pain
Self Care
Linear Models
Sleep
Anxiety
Logistic Models
Smoking
Quality of Life
Depression
Pain
Surveys and Questionnaires
Presenteeism

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis : a cross-sectional UK study. / Espahbodi, Shima; Bassett, Paul; Cavill, Charlotte; Freeth, Mandy; Hole, John; Sengupta, Raj.

In: Clinical and Experimental Rheumatology, Vol. 35, No. 4, 01.07.2017, p. 571-578.

Research output: Contribution to journalArticle

Espahbodi, Shima ; Bassett, Paul ; Cavill, Charlotte ; Freeth, Mandy ; Hole, John ; Sengupta, Raj. / Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis : a cross-sectional UK study. In: Clinical and Experimental Rheumatology. 2017 ; Vol. 35, No. 4. pp. 571-578.
@article{a96ef2a0f93a4f62882644565ed43885,
title = "Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a cross-sectional UK study",
abstract = "OBJECTIVES: To determine factors associated with absenteeism, presenteeism, work productivity loss (WPL), and daily activity impairment in UK patients with AxSpA using standardised measures.METHODS: 490 patients with AxSpA completed (1) Work Productivity and Impairment questionnaire (WPAI), providing measures for absenteeism, presenteeism, WPL and daily activity impairment, and (2) BASDAI, BASFI, BASMI, Jenkins Sleep scale, Patient Global Assessment disease activity (PGA), back pain night and anytime, EQ-5D for mobility, self-care, daily activities, pain/discomfort, anxiety/depression, EQ-VAS Health State Today, FACIT fatigue, for health-related disease factors. Multivariate linear and logistic regression determined associations between WPAI measures and health-related factors.RESULTS: 301(61{\%}) patients provided WPAI measurements, 76{\%} were male, 87{\%} HLA-B27+. Mean (SD) WPAI scores for absenteeism were 5.1{\%}(19.2), presenteeism 22{\%}(24.3), WPL 23.2{\%}(25.7), activity impairment 34.8{\%}(27.3). Absenteeism was associated with higher fatigue levels and more likely in patients with nrAxSpA. Presenteeism and WPL were both associated higher fatigue levels, BASDAI, and BASFI respectively. Daily activity impairment was associated with higher fatigue levels, BASFI, PGA, EQ-VAS, and smoking.CONCLUSIONS: Work productivity and impairment are associated with fatigue, disease activity, and functional ability in UK patients with AxSpA. The strong association of fatigue with all work measures as well as with daily activity impairment emphasises the need to better understand the impact of fatigue on patients' quality of life. Improving fatigue may help to optimise work status.",
author = "Shima Espahbodi and Paul Bassett and Charlotte Cavill and Mandy Freeth and John Hole and Raj Sengupta",
year = "2017",
month = "7",
day = "1",
language = "English",
volume = "35",
pages = "571--578",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "4",

}

TY - JOUR

T1 - Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis

T2 - a cross-sectional UK study

AU - Espahbodi, Shima

AU - Bassett, Paul

AU - Cavill, Charlotte

AU - Freeth, Mandy

AU - Hole, John

AU - Sengupta, Raj

PY - 2017/7/1

Y1 - 2017/7/1

N2 - OBJECTIVES: To determine factors associated with absenteeism, presenteeism, work productivity loss (WPL), and daily activity impairment in UK patients with AxSpA using standardised measures.METHODS: 490 patients with AxSpA completed (1) Work Productivity and Impairment questionnaire (WPAI), providing measures for absenteeism, presenteeism, WPL and daily activity impairment, and (2) BASDAI, BASFI, BASMI, Jenkins Sleep scale, Patient Global Assessment disease activity (PGA), back pain night and anytime, EQ-5D for mobility, self-care, daily activities, pain/discomfort, anxiety/depression, EQ-VAS Health State Today, FACIT fatigue, for health-related disease factors. Multivariate linear and logistic regression determined associations between WPAI measures and health-related factors.RESULTS: 301(61%) patients provided WPAI measurements, 76% were male, 87% HLA-B27+. Mean (SD) WPAI scores for absenteeism were 5.1%(19.2), presenteeism 22%(24.3), WPL 23.2%(25.7), activity impairment 34.8%(27.3). Absenteeism was associated with higher fatigue levels and more likely in patients with nrAxSpA. Presenteeism and WPL were both associated higher fatigue levels, BASDAI, and BASFI respectively. Daily activity impairment was associated with higher fatigue levels, BASFI, PGA, EQ-VAS, and smoking.CONCLUSIONS: Work productivity and impairment are associated with fatigue, disease activity, and functional ability in UK patients with AxSpA. The strong association of fatigue with all work measures as well as with daily activity impairment emphasises the need to better understand the impact of fatigue on patients' quality of life. Improving fatigue may help to optimise work status.

AB - OBJECTIVES: To determine factors associated with absenteeism, presenteeism, work productivity loss (WPL), and daily activity impairment in UK patients with AxSpA using standardised measures.METHODS: 490 patients with AxSpA completed (1) Work Productivity and Impairment questionnaire (WPAI), providing measures for absenteeism, presenteeism, WPL and daily activity impairment, and (2) BASDAI, BASFI, BASMI, Jenkins Sleep scale, Patient Global Assessment disease activity (PGA), back pain night and anytime, EQ-5D for mobility, self-care, daily activities, pain/discomfort, anxiety/depression, EQ-VAS Health State Today, FACIT fatigue, for health-related disease factors. Multivariate linear and logistic regression determined associations between WPAI measures and health-related factors.RESULTS: 301(61%) patients provided WPAI measurements, 76% were male, 87% HLA-B27+. Mean (SD) WPAI scores for absenteeism were 5.1%(19.2), presenteeism 22%(24.3), WPL 23.2%(25.7), activity impairment 34.8%(27.3). Absenteeism was associated with higher fatigue levels and more likely in patients with nrAxSpA. Presenteeism and WPL were both associated higher fatigue levels, BASDAI, and BASFI respectively. Daily activity impairment was associated with higher fatigue levels, BASFI, PGA, EQ-VAS, and smoking.CONCLUSIONS: Work productivity and impairment are associated with fatigue, disease activity, and functional ability in UK patients with AxSpA. The strong association of fatigue with all work measures as well as with daily activity impairment emphasises the need to better understand the impact of fatigue on patients' quality of life. Improving fatigue may help to optimise work status.

UR - http://www.scopus.com/inward/record.url?scp=85028674031&partnerID=8YFLogxK

UR - http://www.clinexprheumatol.org

M3 - Article

C2 - 28240589

AN - SCOPUS:85028674031

VL - 35

SP - 571

EP - 578

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 4

ER -